Adriamycin resistance modulation induced by lonidamine in human breast cancer cells

G. Zupi, A. Molinari, I. D'Agnano, S. Meschini, D. Del Bufalo, P. Matarrese, A. Candiloro, A. Calcabrini, G. Citro, G. Arancia

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The effect of Lonidamine (LND), an energolytic chemosensitizing agent, on the MDR (multidrug resistant) phenotype of a human breast cancer cell line (MCF-7) has been studied. The intracellular adriamycin (ADR) accumulation and distribution, the plasma membrane potential and the P170 glycoprotein phosphorylation, have been analysed after LND treatment. The analysis of the subcellular localisation of ADR in both wild type and resistant MCF-7 cells treated with ADR or ADR + LND revealed that LND induced an ADR intracellular redistribution in both cell lines. MCF-7 ADR resistant cells exposed to LND (50 μg/ml) showed a change in the electrical charges distribution across the plasma membrane and a time-dependent reduction of P170 phosphorylation (70% at 24 hr). These effects were associated with a marked increase in intracellular ADR accumulation in resistant cells.

Original languageEnglish
Pages (from-to)2469-2477
Number of pages9
JournalAnticancer Research
Volume15
Issue number6 B
Publication statusPublished - 1995

Fingerprint

Doxorubicin
Breast Neoplasms
Phosphorylation
Cell Membrane
Cell Line
MCF-7 Cells
lonidamine
Membrane Potentials
Glycoproteins
Phenotype

Keywords

  • Adriamycin
  • Lonidamine
  • MCF-7
  • MDR
  • P170

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Zupi, G., Molinari, A., D'Agnano, I., Meschini, S., Del Bufalo, D., Matarrese, P., ... Arancia, G. (1995). Adriamycin resistance modulation induced by lonidamine in human breast cancer cells. Anticancer Research, 15(6 B), 2469-2477.

Adriamycin resistance modulation induced by lonidamine in human breast cancer cells. / Zupi, G.; Molinari, A.; D'Agnano, I.; Meschini, S.; Del Bufalo, D.; Matarrese, P.; Candiloro, A.; Calcabrini, A.; Citro, G.; Arancia, G.

In: Anticancer Research, Vol. 15, No. 6 B, 1995, p. 2469-2477.

Research output: Contribution to journalArticle

Zupi, G, Molinari, A, D'Agnano, I, Meschini, S, Del Bufalo, D, Matarrese, P, Candiloro, A, Calcabrini, A, Citro, G & Arancia, G 1995, 'Adriamycin resistance modulation induced by lonidamine in human breast cancer cells', Anticancer Research, vol. 15, no. 6 B, pp. 2469-2477.
Zupi G, Molinari A, D'Agnano I, Meschini S, Del Bufalo D, Matarrese P et al. Adriamycin resistance modulation induced by lonidamine in human breast cancer cells. Anticancer Research. 1995;15(6 B):2469-2477.
Zupi, G. ; Molinari, A. ; D'Agnano, I. ; Meschini, S. ; Del Bufalo, D. ; Matarrese, P. ; Candiloro, A. ; Calcabrini, A. ; Citro, G. ; Arancia, G. / Adriamycin resistance modulation induced by lonidamine in human breast cancer cells. In: Anticancer Research. 1995 ; Vol. 15, No. 6 B. pp. 2469-2477.
@article{566a020b881d4018b7ae92578defd51f,
title = "Adriamycin resistance modulation induced by lonidamine in human breast cancer cells",
abstract = "The effect of Lonidamine (LND), an energolytic chemosensitizing agent, on the MDR (multidrug resistant) phenotype of a human breast cancer cell line (MCF-7) has been studied. The intracellular adriamycin (ADR) accumulation and distribution, the plasma membrane potential and the P170 glycoprotein phosphorylation, have been analysed after LND treatment. The analysis of the subcellular localisation of ADR in both wild type and resistant MCF-7 cells treated with ADR or ADR + LND revealed that LND induced an ADR intracellular redistribution in both cell lines. MCF-7 ADR resistant cells exposed to LND (50 μg/ml) showed a change in the electrical charges distribution across the plasma membrane and a time-dependent reduction of P170 phosphorylation (70{\%} at 24 hr). These effects were associated with a marked increase in intracellular ADR accumulation in resistant cells.",
keywords = "Adriamycin, Lonidamine, MCF-7, MDR, P170",
author = "G. Zupi and A. Molinari and I. D'Agnano and S. Meschini and {Del Bufalo}, D. and P. Matarrese and A. Candiloro and A. Calcabrini and G. Citro and G. Arancia",
year = "1995",
language = "English",
volume = "15",
pages = "2469--2477",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 B",

}

TY - JOUR

T1 - Adriamycin resistance modulation induced by lonidamine in human breast cancer cells

AU - Zupi, G.

AU - Molinari, A.

AU - D'Agnano, I.

AU - Meschini, S.

AU - Del Bufalo, D.

AU - Matarrese, P.

AU - Candiloro, A.

AU - Calcabrini, A.

AU - Citro, G.

AU - Arancia, G.

PY - 1995

Y1 - 1995

N2 - The effect of Lonidamine (LND), an energolytic chemosensitizing agent, on the MDR (multidrug resistant) phenotype of a human breast cancer cell line (MCF-7) has been studied. The intracellular adriamycin (ADR) accumulation and distribution, the plasma membrane potential and the P170 glycoprotein phosphorylation, have been analysed after LND treatment. The analysis of the subcellular localisation of ADR in both wild type and resistant MCF-7 cells treated with ADR or ADR + LND revealed that LND induced an ADR intracellular redistribution in both cell lines. MCF-7 ADR resistant cells exposed to LND (50 μg/ml) showed a change in the electrical charges distribution across the plasma membrane and a time-dependent reduction of P170 phosphorylation (70% at 24 hr). These effects were associated with a marked increase in intracellular ADR accumulation in resistant cells.

AB - The effect of Lonidamine (LND), an energolytic chemosensitizing agent, on the MDR (multidrug resistant) phenotype of a human breast cancer cell line (MCF-7) has been studied. The intracellular adriamycin (ADR) accumulation and distribution, the plasma membrane potential and the P170 glycoprotein phosphorylation, have been analysed after LND treatment. The analysis of the subcellular localisation of ADR in both wild type and resistant MCF-7 cells treated with ADR or ADR + LND revealed that LND induced an ADR intracellular redistribution in both cell lines. MCF-7 ADR resistant cells exposed to LND (50 μg/ml) showed a change in the electrical charges distribution across the plasma membrane and a time-dependent reduction of P170 phosphorylation (70% at 24 hr). These effects were associated with a marked increase in intracellular ADR accumulation in resistant cells.

KW - Adriamycin

KW - Lonidamine

KW - MCF-7

KW - MDR

KW - P170

UR - http://www.scopus.com/inward/record.url?scp=0029554704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029554704&partnerID=8YFLogxK

M3 - Article

C2 - 8669810

AN - SCOPUS:0029554704

VL - 15

SP - 2469

EP - 2477

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 B

ER -